249 related articles for article (PubMed ID: 28095588)
1. Potent effects of dioscin against pancreatic cancer via miR-149-3P-mediated inhibition of the Akt1 signalling pathway.
Si L; Xu L; Yin L; Qi Y; Han X; Xu Y; Zhao Y; Liu K; Peng J
Br J Pharmacol; 2017 Apr; 174(7):553-568. PubMed ID: 28095588
[TBL] [Abstract][Full Text] [Related]
2. Potent effects of dioscin against hepatocellular carcinoma through regulating TP53-induced glycolysis and apoptosis regulator (TIGAR)-mediated apoptosis, autophagy, and DNA damage.
Mao Z; Han X; Chen D; Xu Y; Xu L; Yin L; Sun H; Qi Y; Fang L; Liu K; Peng J
Br J Pharmacol; 2019 Apr; 176(7):919-937. PubMed ID: 30710454
[TBL] [Abstract][Full Text] [Related]
3. Potent effects of dioscin against gastric cancer in vitro and in vivo.
Zhao X; Xu L; Zheng L; Yin L; Qi Y; Han X; Xu Y; Peng J
Phytomedicine; 2016 Mar; 23(3):274-82. PubMed ID: 26969381
[TBL] [Abstract][Full Text] [Related]
4. Dioscin suppresses human laryngeal cancer cells growth via induction of cell-cycle arrest and MAPK-mediated mitochondrial-derived apoptosis and inhibition of tumor invasion.
Si L; Zheng L; Xu L; Yin L; Han X; Qi Y; Xu Y; Wang C; Peng J
Eur J Pharmacol; 2016 Mar; 774():105-17. PubMed ID: 26849940
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of dioscin against cisplatin-induced nephrotoxicity via the microRNA-34a/sirtuin 1 signalling pathway.
Zhang Y; Tao X; Yin L; Xu L; Xu Y; Qi Y; Han X; Song S; Zhao Y; Lin Y; Liu K; Peng J
Br J Pharmacol; 2017 Aug; 174(15):2512-2527. PubMed ID: 28514495
[TBL] [Abstract][Full Text] [Related]
6. Network Pharmacology and Experimental Evidence Reveal Dioscin Suppresses Proliferation, Invasion, and EMT via AKT/GSK3b/mTOR Signaling in Lung Adenocarcinoma.
Mao W; Yin H; Chen W; Zhao T; Wu S; Jin H; Du B; Tan Y; Zhang R; He Y
Drug Des Devel Ther; 2020; 14():2135-2147. PubMed ID: 32546976
[TBL] [Abstract][Full Text] [Related]
7. Dioscin suppresses hepatocellular carcinoma tumor growth by inducing apoptosis and regulation of TP53, BAX, BCL2 and cleaved CASP3.
Zhang G; Zeng X; Zhang R; Liu J; Zhang W; Zhao Y; Zhang X; Wu Z; Tan Y; Wu Y; Du B
Phytomedicine; 2016 Nov; 23(12):1329-1336. PubMed ID: 27765352
[TBL] [Abstract][Full Text] [Related]
8. Dioscin induces prostate cancer cell apoptosis through activation of estrogen receptor-β.
Tao X; Xu L; Yin L; Han X; Qi Y; Xu Y; Song S; Zhao Y; Peng J
Cell Death Dis; 2017 Aug; 8(8):e2989. PubMed ID: 28796245
[TBL] [Abstract][Full Text] [Related]
9. Dioscin alleviates lipopolysaccharide-induced inflammatory kidney injury via the microRNA let-7i/TLR4/MyD88 signaling pathway.
Qi M; Yin L; Xu L; Tao X; Qi Y; Han X; Wang C; Xu Y; Sun H; Liu K; Peng J
Pharmacol Res; 2016 Sep; 111():509-522. PubMed ID: 27431331
[TBL] [Abstract][Full Text] [Related]
10. Embelin suppresses growth of human pancreatic cancer xenografts, and pancreatic cancer cells isolated from KrasG12D mice by inhibiting Akt and Sonic hedgehog pathways.
Huang M; Tang SN; Upadhyay G; Marsh JL; Jackman CP; Shankar S; Srivastava RK
PLoS One; 2014; 9(4):e92161. PubMed ID: 24694877
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-31 inhibits lung adenocarcinoma stem-like cells via down-regulation of MET-PI3K-Akt signaling pathway.
Hou C; Sun B; Jiang Y; Zheng J; Yang N; Ji C; Liang Z; Shi J; Zhang R; Liu Y; Ye C; Zuo P
Anticancer Agents Med Chem; 2016; 16(4):501-18. PubMed ID: 26299665
[TBL] [Abstract][Full Text] [Related]
12. Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice.
Zhao M; Tang SN; Marsh JL; Shankar S; Srivastava RK
Cancer Lett; 2013 Sep; 337(2):210-7. PubMed ID: 23684930
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
14. Dioscin inhibits human endometrial carcinoma proliferation via G0/G1 cell cycle arrest and mitochondrial-dependent signaling pathway.
Li XL; Ma RH; Ni ZJ; Thakur K; Cespedes-Acuña CL; Wang S; Zhang JG; Wei ZJ
Food Chem Toxicol; 2021 Feb; 148():111941. PubMed ID: 33359023
[TBL] [Abstract][Full Text] [Related]
15. Dioscin inhibits stem-cell-like properties and tumor growth of osteosarcoma through Akt/GSK3/β-catenin signaling pathway.
Liu W; Zhao Z; Wang Y; Li W; Su Q; Jia Q; Zhang J; Zhang X; Shen J; Yin J
Cell Death Dis; 2018 Mar; 9(3):343. PubMed ID: 29497056
[TBL] [Abstract][Full Text] [Related]
16. Dioscin inhibits colon tumor growth and tumor angiogenesis through regulating VEGFR2 and AKT/MAPK signaling pathways.
Tong Q; Qing Y; Wu Y; Hu X; Jiang L; Wu X
Toxicol Appl Pharmacol; 2014 Dec; 281(2):166-73. PubMed ID: 25111127
[TBL] [Abstract][Full Text] [Related]
17. Dioscin-induced apoptosis of human LNCaP prostate carcinoma cells through activation of caspase-3 and modulation of Bcl-2 protein family.
Chen J; Li HM; Zhang XN; Xiong CM; Ruan JL
J Huazhong Univ Sci Technolog Med Sci; 2014 Feb; 34(1):125-130. PubMed ID: 24496691
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of dioscin against intestinal ischemia/reperfusion injury via adjusting miR-351-5p-mediated oxidative stress.
Hu Y; Mao Z; Xu L; Yin L; Tao X; Tang Z; Qi Y; Sun P; Peng J
Pharmacol Res; 2018 Nov; 137():56-63. PubMed ID: 30240824
[TBL] [Abstract][Full Text] [Related]
19. Dioscin ameliorates intestinal ischemia/reperfusion injury via adjusting miR-351-5p/MAPK13-mediated inflammation and apoptosis.
Zheng L; Han X; Hu Y; Zhao X; Yin L; Xu L; Qi Y; Xu Y; Han X; Liu K; Peng J
Pharmacol Res; 2019 Jan; 139():431-439. PubMed ID: 30503840
[TBL] [Abstract][Full Text] [Related]
20. Disocin prevents postmenopausal atherosclerosis in ovariectomized LDLR-/- mice through a PGC-1α/ERα pathway leading to promotion of autophagy and inhibition of oxidative stress, inflammation and apoptosis.
Yang Q; Wang C; Jin Y; Ma X; Xie T; Wang J; Liu K; Sun H
Pharmacol Res; 2019 Oct; 148():104414. PubMed ID: 31449974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
